188 related articles for article (PubMed ID: 35331716)
21. 'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries.
Titeca G; Goudetsidis L; Francq B; Sampogna F; Gieler U; Tomas-Aragones L; Lien L; Jemec GBE; Misery L; Szabo C; Linder D; Evers AWM; Halvorsen JA; Balieva F; Szepietowski J; Romanov D; Marron SE; Altunay IK; Finlay AY; Salek SS; Kupfer J; Dalgard FJ; Poot F
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):406-411. PubMed ID: 31465592
[TBL] [Abstract][Full Text] [Related]
22. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.
Shi Q; Duvic M; Osei JS; Hordinsky MK; Norris DA; Price VH; Amos CI; Christiano AM; Mendoza TR
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S49-50. PubMed ID: 24326555
[TBL] [Abstract][Full Text] [Related]
23. The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata.
Gandhi K; Shy ME; Ray M; Fridman M; Vaghela S; Mostaghimi A
Dermatol Ther (Heidelb); 2023 Jan; 13(1):285-298. PubMed ID: 36484916
[TBL] [Abstract][Full Text] [Related]
24. Development of the alopecia areata symptom impact scale.
Mendoza TR; Osei JS; Shi Q; Duvic M
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S51-2. PubMed ID: 24326557
[TBL] [Abstract][Full Text] [Related]
25. Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.
Macey J; Kitchen H; Aldhouse NVJ; Burge RT; Edson-Heredia E; McCollam JS; Isaka Y; Torisu-Itakura H
Dermatol Ther (Heidelb); 2021 Apr; 11(2):433-447. PubMed ID: 33464474
[TBL] [Abstract][Full Text] [Related]
26. Comparison of quality of life in patients with androgenetic alopecia and alopecia areata.
Gonul M; Cemil BC; Ayvaz HH; Cankurtaran E; Ergin C; Gurel MS
An Bras Dermatol; 2018; 93(5):651-658. PubMed ID: 30156613
[TBL] [Abstract][Full Text] [Related]
27. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
; Moussa A; Bennett M; Wall D; Meah N; York K; Bokhari L; Asfour L; Rees H; Abraham LS; Asz-Sigall D; Basmanav FB; Bergfeld W; Betz RC; Bhoyrul B; Blume-Peytavi U; Callender V; Chitreddy V; Combalia A; Cotsarelis G; Craiglow B; Dhurat R; Donovan J; Doroshkevich A; Eisman S; Farrant P; Ferrando J; Gadzhigoroeva A; Green J; Grimalt R; Harries M; Hordinsky M; Irvine A; Jolliffe V; Kaiumov S; King B; Lee J; Lee WS; Li J; Lortkipanidze N; McMichael A; Mesinkovska NA; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Rudnicka L; Corralo DS; Senna M; Shapiro J; Sharma P; Siliuk T; Starace M; Suchonwanit P; Takwale A; Tosti A; Vañó-Galván S; Visser WI; Vogt A; Wade M; Yip L; Zhou C; Sinclair R
JAMA Dermatol; 2024 Mar; 160(3):341-350. PubMed ID: 38324292
[TBL] [Abstract][Full Text] [Related]
28. Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study.
Mesinkovska N; King B; Mirmirani P; Ko J; Cassella J
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S62-S68. PubMed ID: 33099390
[TBL] [Abstract][Full Text] [Related]
29. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials.
Piraccini BM; Ohyama M; Craiglow B; Bewley A; Ding Y; Chen YF; Dutronc Y; Pierce E; Durand F; Mostaghimi A
J Dermatolog Treat; 2023 Dec; 34(1):2227299. PubMed ID: 37381691
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample.
Aranishi T; Ito T; Fukuyama M; Isaka Y; Mackie DS; King-Concialdi K; Senglaub SS; Jaffe DH; Shimomura Y; Ohyama M
J Dermatol; 2023 Jan; 50(1):26-36. PubMed ID: 36412271
[TBL] [Abstract][Full Text] [Related]
31. Applying the Common Sense Model to predicting quality of life in alopecia areata: The role of illness perceptions and coping strategies.
Willemse H; van der Doef M; van Middendorp H
J Health Psychol; 2019 Sep; 24(11):1461-1472. PubMed ID: 29355049
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life of adult and adolescent patients living with alopecia areata in Australia.
Sinclair R; Eisman S; Lee CMY; Hitschfeld M; Witcombe D; Pereira CDF
Australas J Dermatol; 2024 May; ():. PubMed ID: 38764404
[TBL] [Abstract][Full Text] [Related]
33. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study.
Thaçi D; Tziotzios C; Ito T; Ko J; Karadağ AS; Fang H; Edwards RA; Bonfanti G; Wolk R; Tran H; Law E
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2621-2634. PubMed ID: 37707764
[TBL] [Abstract][Full Text] [Related]
34. Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Mesinkovska N; Ko JM; King BA
Qual Life Res; 2023 May; 32(5):1319-1327. PubMed ID: 35821174
[TBL] [Abstract][Full Text] [Related]
35. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata.
Al-Mutairi N; Eldin ON
Indian J Dermatol Venereol Leprol; 2011; 77(4):489-93. PubMed ID: 21727697
[TBL] [Abstract][Full Text] [Related]
36. Alopecia areata and health-related quality of life: a systematic review and meta-analysis.
Rencz F; Gulácsi L; Péntek M; Wikonkál N; Baji P; Brodszky V
Br J Dermatol; 2016 Sep; 175(3):561-71. PubMed ID: 26914830
[TBL] [Abstract][Full Text] [Related]
37. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study.
Majid I; Sameem F; Sultan J; Aleem S
J Cosmet Dermatol; 2021 Aug; 20(8):2565-2570. PubMed ID: 34129730
[TBL] [Abstract][Full Text] [Related]
38. Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.
Chernyshov PV; Tomas-Aragones L; Finlay AY; Manolache L; Marron SE; Sampogna F; Spillekom-van Koulil S; Pustisek N; Suru A; Evers AWM; Salavastru C; Svensson A; Abeni D; Blome C; Poot F; Jemec GBE; Linder D; Augustin M; Bewley A; Salek SS; Szepietowski JC
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1614-1621. PubMed ID: 34107093
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.
Liu LY; King BA; Craiglow BG
J Am Acad Dermatol; 2016 Oct; 75(4):806-812.e3. PubMed ID: 27436156
[TBL] [Abstract][Full Text] [Related]
40. Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Br J Dermatol; 2020 Dec; 183(6):1065-1072. PubMed ID: 32163589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
